chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After first shot - soreness in upper arm at injection site and a headache for a couple days; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (After first shot - soreness in upper arm at injection site and a headache for a couple days) and HEADACHE (Headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 024M20A) for COVID-19 vaccination.     No concomitant medications reported.  Concurrent medical conditions included Drug allergy (sulfa drug allergy).   On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (After first shot - soreness in upper arm at injection site and a headache for a couple days) and HEADACHE (Headache). At the time of the report, VACCINATION SITE PAIN (After first shot - soreness in upper arm at injection site and a headache for a couple days) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient added that she experienced soreness in her upper arm at the injection site and a headache for a couple of days after the first dose of the vaccine. She has not used any treatments for either adverse events. She does not take any other medications.   This case was linked to MOD-2021-032084 (Patient Link).
REDNESS ON AREA, NO PAIN, NO FEVER, NOT TENDER, LENGTH 70 MM AND WIDTH 65 MM
Employee reported on 5/14/2023 with complaints of itching at injection site, Noted warmth and redness (1.75"x2" in size) to injection site.
chills, fever up to 103, vomited x 1, aching, course 3 days;
Sore arm into 2/3/21;  stiff neck within 2 hours of vaccine and lasted 24+ hours;  chills and slight fever becoming worse at dusk- fever was only 100.4 and dropped down after 18 hours; total body aches progressively increased until  3:30am 2/2;  very dry mouth throughout the 1st night;  slight nausea/no appetite for 28 hours; no energy; didn?t feel like reading or socializing; Shortness of breath the next day and today. Feel recovered today
soreness at the side of her neck; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 26Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NECK PAIN (non-serious) with onset 26Mar2021, outcome "unknown", described as "soreness at the side of her neck". Therapeutic measures were taken as a result of neck pain.  Additional information: Caller received the Pfizer Covid-19 vaccine first dose this morning, 26Mar2021 and she experienced soreness at the side of her neck. Her 2nd dose will be on 16Apr2021. She wanted to know if Advil will work as well after taking Tylenol..  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient felt achy, fever, and fatigue for 2 days. Symptoms resolved without treatment.
Severe headache began 5:30pm on 09/04/03 rash on chest and face 9:30pm on 09/04/03.  Rash gone am 09/05/03. Still has some headache 3pm on 09/05/03.
Tonic clonic seizures on April 15, had 3 possibly 4 tonic clonic seizures lasting less than 5 minutes each, resulting in ER visit and hospitalization. Loaded with DILANTIN, KEPPRA, and ATIVAN which stopped seizures. Possible short duration seizures since April 16, but largely controlled on KEPPRA.
Dizziness Heart palpitations Pain in chest wall Shortness of breath Spleen pain Liver pain
Myalgia, Malaise, Chills Narrative: Had body aches, chills, fatigue as well as injection site soreness
Throat not feeling right / fullness. Denies any other s/s. Reports Hx of anaphylaxis with other vaccines, but never with flu vaccine. Took one tablet of Benadryl 25 mg .
Day 1: nausea, tired Day 2: severe headache, very dizzy,  overall pain, chills, nausea, brief ringing in ears, weakness - bedridden Day 3: bad headache, pain, nausea, tired, unable to do much Day 4: intermittent headache, nausea, tired, unable to do much Day 5: headache, nausea, tired, unsteady after shoveling
Altered Mental state; Weakness, confusion, hospitalization by ambulance, fever 102 for 3 days; impaired speech, upper body shaking Reaction to 1st vaccine required hospitalization with similar symptoms but not as severe;  Covid fog.  He had similar symptoms to covid last summer with lingering problem.  Hospital wanted to diagnose as Parkinsons Disease but he was cleared for Parkinsons last fall and last year.  Hospital did not want to file an AE report and did not know the process.
After immunizations patient began to leave He returned shortly after c/o Chest pain to Dad.  Oxygen 98%; HR 91 and regular.   Dr. into room.  Patient given tylenol Breathing appears normal.  No rash.  We monitoring at 10:48.   At 10:49 started c/o hands itching and getting rash to legs.  Dad thinks rash started to right leg where MMR was given.   Red and slightly raised blanches 3 areas to legs at this time.    At this point dad states mom says he's had allergic reaction to an immunization in past.  But think had to do with egg allergy??   Given Benadryl and it worked.  Giving Benadryl 25 mg at this time.    Rash continues to worsen to lower extremities and to abdomen Chest pain has improved.  No SOB Some facial blanching now and mild facial swelling We are giving 20 mg Pred Also giving epi 1mg/ml   Giving 0.15 mg SQ into right leg.   12:03:  No CP or SOB.  No tongue swelling.  Still has diffuse slightly raised red rash to lower extremities and lower abdomen.  Facial blanching has improved a little.  No facial swelling.  He appears calm.  VSS.       Patient discharged after monitoring one hour after epi injection  No RASH now.  No facial blanching.  No CP, No SOB No symptoms at this time Take above Rx's.     Strict ER warnings given.  Return of rash, SOB, CP, facial/lip swelling.  see continuation page >>>>
Lg lemon sized welt - hot, painful, itchy, hard. Benadryl, warm compresses.
Severe migraine; body aches; fever; vomiting; diarrhea; nausea; exhaustion/ unable to leave bed; This is a spontaneous report from a contactable consumer (patient) received via COVID-19 Vaccine Adverse Event Reporting System. A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EN6203), via an unspecified route of administration, administered in the left arm on 26Feb2021, at 11:30 (at the age of 45 years old) as dose 1, single for COVID-19 immunisation. The patient has no known allergies and other medical history. She was not pregnant at the time of report. She was not tested for COVID-19 prior to vaccination. The patient's concomitant medications were not reported. She did not receive any other vaccines within four weeks prior to the COVID vaccine and other medications in two weeks before the vaccination. On 27Feb2021, at 00:00, the patient experienced severe migraine, body aches, fever, vomiting, diarrhea, nausea, exhaustion, and unable to leave bed. The patient underwent lab tests and procedures which included nasal swab: negative on 28Feb2021. No therapeutic measures were taken as a result of the events. The patient recovered from the evens on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Body felt hot but no fever, like my blood was hot in my veins, blood sugar 147, pluse 144, arm very painful, felt weak, urinated about every 1/2 hr. felt a little nauseous, the next day didn?t want to eat, left lymph node felt like a golf ball Right now my right lymph node hurts a little during the day and night
I started vomiting 12 hours from when I received the shot. Hot and cold sweats. Stomach cramping. As the next few days went on, I was feeling foggy, unmotivated and extremely depressed.
Information has been received from a pharmacist referring to a 62 year old female patient. The patient had no pertinent medical history and no drug reactions or allergies. On 01-DEC-2015 the patient was vaccinated with ZOSTAVAX vial, (L032399 expired date 26-NOV-2016) 0.65 ml, subcutaneously. Then on 02-DEC-2015 the same unspecified patient received dose of ZOSTAVAX vial, (L032399 expired date 26-NOV-2016) 0.65 ml, subcutaneously. Concomitant therapies included LEXAPRO. On 03-DEC-205, the patient called to report itching and redness at injection site that began on an unspecified date in December 2015. No lab diagnostics studies were performed. No treatment was given for the events. The outcome of the events was reported as not recovered. Causality was not provided. Additional information has been requested.
Patient began to complain of soreness and redness at injection site within 15-20 minutes of administration. Patient returned to work and by the time she got home that evening of 6/18 (6-8 PM), she complained of generalized whole body pain, a low grade fever (approximately 101-102 F), and headache. She mentioned her intense muscle soreness in her arms had progressed to the point that she could not lift her arms above her shoulders without extreme pain. Patient reported no nausea, vomiting, rash, or symptoms of an anaphylactic reaction. Patient reported she took some TYLENOL and an ALEVE OTC, which helped with the headache. Patient reported she barely slept that night due to the symptoms. Patient reported back to work the next day on 6/19. Generalized whole body pain was still present but other symptoms had subsided. All symptoms had ceased by the time patient called the pharmacy on 6/20. Patient reported that she intended to complete the series, and would pretreat herself to minimize/prevent the same reaction from reoccurring.
This spontaneous report as received from a nurse refers to a 10 years old female patient with no pertinent medical history and no drug reactions or allergies. On 04-AUG-2015, the patient was vaccinated intramuscularly with an unknown dose of GARDASIL 9 (lot# reported as L006547 (invalid lot number), expiry date: 04-MAR-2017). No concomitant medications were administered. On 16-AUG-2015, the patient experienced pain at the injection site. No lab diagnostics studies were performed. The outcome of injection site pain was reported as not recovered. The medical attention was sought via a call to the physician performed by the patient's mother. The relatedness between the events and dose of GARDASIL 9 was not reported. Additional information has been requested.
Administered vaccine after 33 days in the refrigerator; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator) in a 40-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant or treatment medications were reported.
Dull pain at site of injection, started same day, very severe day 3-5, then slowly subsided. Rash, papular, vertically along the arm, from site of injection, resolved over 4-5d.
Pt felt light headed and went pale post Men B vaccine. Pt had to lye down x20min in office with ice packs due to heat. Pt was very nausea and had a mild headache. After about 30-40 min pt was well enough to leave office, but didn't feel better till next am.
Symptoms: severe generalized pain, dizziness, muscle weakness, muscle spasms, numbness, migraines, memory problems, brain fog, insomnia, shortness of breath, tingling, muscle twitching, fatigue, muscle cramping, night sweats, shivering when not cold, etc. Treatment: chiropractic adjustments 1-3 times a week, regular MD visits, rheumatologist visit, neurologist visit, second rheumatologist visit scheduled, etc.
Really bad rash on her arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Really bad rash on her arm) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced RASH (Really bad rash on her arm). The patient was treated with HYDROCORTISONE (CORTISONE [HYDROCORTISONE]) at an unspecified dose and frequency. At the time of the report, RASH (Really bad rash on her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This spontaneous report was received from a medical assistant regarding a patient of unknown age and gender. Information on their concurrent conditions, pertinent medical history and drug allergies were not reported. On 16-MAR-2016, the patient was vaccinated with improperly stored (Oka/Merck) VARIVAX (lot # L027288, expiry date 21-JUL-2017)(dose, frequency, route and anatomical location were not reported) (incorrect product storage). Concomitant medications were not reported. No adverse effects were reported. There were no Product Quality Concern (PQC) involved. Temperature at which the administered product was stored was 9.3 Fahrenheit, there were no previous temperature excursions performed. This is one of several reports received from same reporter. Additional information has been requested.
This spontaneous report as received from a physician via company representative refers to a male patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, route and lot# were not reported). On an unknown date the patient experienced a severe case of shingles. The outcome of case of shingles was unknown. The patient visited office to seek help. Causality was not reported. Additional information has been requested.
12 YEAR OLD PATIENT RECEIVED PFIZER PEDIATRIC FORMULATION (5-11) FOR 2ND DOSE IN SERIES.  PATIENT RECEIVED CORRECT PFIZER 12 YEAR OLD AND UP DOSE FOR FIRST COVID VACCINATION
This spontaneous report was received from a registered nurse and refers to unspecified multiple patients of unknown age and gender. No information about the patients' medical history, concurrent conditions, drug reactions or allergies and concomitant medications was provided. On unknown dates, the patients were vaccinated with improperly stored ROTATEQ orally, lot # M002254 expiration date: 15-NOV-2017, lot# M004508, expiration date: 29-JUN-2017, lot# M012495, expiration date: 09-OCT-2017, lot# M025568, expiration date: 07-NOV-2017 (dose was not reported). The temperature excursion ranged from 32 to 35 degrees Fahrenheit for 24 hours. There was no previous temperature excursion. Digital data logger was used. Product quality complaint was not involved. This is one of three reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1703USA013069: US-009507513-1703USA013068.
Patient reports itching, hives, swelling on skin, numbness on face, and blisters on ears approximately 1 hour after receiving vaccine. Pt reports treating symptoms with Benadryl and hydrocortisone cream OTC. Pt reports that her status has been improving.
The first 4 days I had a high fever 101.3, I had the chills, body ache, extremely fatigue.  That lasted from Sunday to Friday. Then for the next 2 to 4 weeks I was still fatigued, I could barely function at work.  I started to lose weight.  I work in a doctor?s office and I told the doctor that I did not feel well.  I went from 108 to 99 pounds.  In March I started to have the shakes and I went to see my PCP.  He did not know what to do but he did bloodwork.  The results the TSH went to 0.01 level.  They increased my Tapazole for my thyroid.  Two weeks later I got my blood drawn, TSH was even worse 0.005.  He increased my does again of Tapazole.   I had my blood drawn again 4 weeks later, no change in the TSH.  The doctor stated she might have went into immune overdrive due to second dose of vaccine.   She feels still so exhausted, and my muscle mass is gone.  She is not able to do activities that she use to do.
This is a 72y.o. male with a PMHx of COPD, HTN, PTSD, and schizophrenia who presents to ED with a chief complaint of shortness of breath, wheezing, and generalized myalgias. Patient COVID test is positive. He had Moderna vaccine x 3 for COVID. Patient still has congestive coughing. No bloody sputum. He denies chest pain, fever, chills, n/v/d, abdominal pain, headache, dizziness, lightheadedness, or LOC. Denies history of renal failure. Denies hematuria or dysuria. No other acute complaints at this time.    On Home O2, chronic resp failure w hypoxia Seen in ER . Poor historian. Tob abuse disorder/ copd. No increased work of breathing. Non-labored resp status
Developed pseudogout in his elbow; This spontaneous case was reported by a consumer and describes the occurrence of CHONDROCALCINOSIS PYROPHOSPHATE (Developed pseudogout in his elbow) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHONDROCALCINOSIS PYROPHOSPHATE (Developed pseudogout in his elbow). At the time of the report, CHONDROCALCINOSIS PYROPHOSPHATE (Developed pseudogout in his elbow) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.   This case was linked to -MODERNATX, INC.-MOD-2021-160528 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  -MODERNATX, INC.-MOD-2021-160528:MOD21-160528 - Same reporter
patient received a .25ml dose when they should've received a .5ml dose.  I've worked with our health department and will be contacting the patient to inform them and encourage another .5ml dose 8 weeks after the .25ml dose was given.
Fatigue; This spontaneous case was reported by a physician and describes the occurrence of FATIGUE (Fatigue) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medication history was reported by the provider.  Concomitant products included ADALIMUMAB (HUMIRA) for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment medications were provided   Reporter did not allow further contact
got the shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, 2 weeks after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The case was reported by the consumer for herself or himself. The age at vaccination was not reported. The patient received the Shingrix vaccine and two weeks later experienced shingles. The patient need to know the dosage.  The patient stated that, everything site he or she looked on did not provide the dosage.  The patient need the dosage for the report. No further information was reported.
Deltoid swelling, spreading cellulitis with erythema, significant induration, and decreased range of motion, was at site of DTaP, other sites ok.
Acute onset, profound, visual disturbance. distortion.  Bilateral flashing lights and image defect within eyes, could not read, or walk safely.  Accompanied by respiratory/chest constriction/feeling like not enough O2 in air. Symptoms resolved spontaneously (total duration of symptoms estimated 45--60 minutes) before exam in Emergency Room. In the evening, pupils felt strange, like recovering from eye dilation drops.   No treatment except ED exam.
Rash/blisters on one side of face. Doctor originally diagnosed as staff infection and treated with antibiotics. Did not get better and doctor diagnosed as shingles and now taking medicine for it.
Erythema, heat, mild swelling at site of DTaP and IPV injections.
The injection site was bruised; burning sensation; when the vaccine went into my arm to the point where my eyes watered; goosebumps; violently throwing up; extreme chills; diarrhea; uncontrollable shakes; muscle joint aches; muscle joint aches; extremely tired; fingers were very very cold; This is a spontaneous report received from a contactable consumer (patient).   A 51-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot number: EN6204) via an unspecified route of administration at left arm on 04Mar2021 12:30 (at the age of 51-year-old) as dose 1, single for COVID-19 immunisation. Medical history included High blood pressure, Cholesterol medication, Penicillin allergy, Known Allergies_Kiwis. Patient was not pregnant at the time of vaccination. Patient did not receive any other vaccines within 4 weeks. Patient do not have COVID-19 prior vaccination and since the vaccination. patient has not been tested for COVID-19. Patient receive other medications in 2 weeks of time as High blood pressure, Cholesterol medication. The patient experienced the injection site was bruised, burning sensation, when the vaccine went into my arm to the point where my eyes watered, goosebumps, violently throwing up, extreme chills, diarrhea, uncontrollable shakes, muscle joint aches, extremely tired, fingers were very very cold on 04Mar2021 14:00. Outcome of all events was recovered on an unspecified date.   No follow-up attempts are possible. No further information is expected
Initially injection pain and numbness to arm. From day 3 on to present: fatigue, malaise, elevated blood pressure, dizziness and facial flushing.
He slept for 18 hours, which is not typical for him. And this is the exact same thing his brother did at the same age.
Pt received YF VAX for travel plans at 12:25. Had Pt stay for observation 45 mins. At 1:00 pm tongue tingle. 10 mins later mouth tingle. 911 called and ambulance ride 1:15 PM.